FIB-4 Calculator
Use this FIB-4 calculator to turn your age, AST, ALT and platelet count into a FIB-4 score and see what your liver fibrosis risk band means.
Updated October 22, 2026
Medical Disclaimer: This calculator gives a general estimate for education only and cannot diagnose a condition. Share your result with your doctor or the clinician who ordered your test, and do not start, stop or change any medicine based on it. Read our full Medical Disclaimer.
How the FIB-4 Score Is Calculated
The FIB-4 index (Fibrosis-4) is a score built from four routine numbers: your age, two liver enzymes called AST and ALT, and your platelet count. Doctors use it as a quick first check for advanced scarring of the liver. It needs no extra test, because the numbers usually come from blood work you have already had.
What FIB-4 Measures
Fibrosis is scar tissue that builds up in the liver after long-term damage. It is graded from F0 (no scarring) to F4 (cirrhosis), and advanced fibrosis means stage F3 (bridging fibrosis) or F4⁴. FIB-4 does not see scar tissue directly. It estimates how likely advanced fibrosis is. The enzymes reflect stress on liver cells, and the platelet count reflects changes in the spleen that come with scarring⁵. FIB-4 does not measure liver fat, and it cannot tell what is causing a liver problem.
The Formula
FIB-4 = (Age x AST) / (Platelets x √ALT)
Age in years, AST and ALT in U/L, platelets in 10^9/L
The score was developed by Sterling and colleagues in 2006 in people with HIV and hepatitis C¹.
How This Calculator Computes Your Result
Enter your age and the AST, ALT and platelet count from the same blood test. Older reports may call AST "SGOT" and ALT "SGPT". AST and ALT can be entered in U/L (the same number as IU/L) or in µkat/L, which the tool multiplies by 60. Platelets reported as 10^9/L, 10^3/µL, K/µL or 10^3/mm3 are all the same number, for example 250. If your report shows the full count, such as 250,000 per µL, the tool divides by 1,000. The score is rounded to two decimals, and the band is set from that rounded number. From age 65, the tool raises the low-risk cutoff to 2.00. It adds a note if you are 35 or younger, if your platelets are outside the usual 150 to 400⁷, or if AST or ALT is above 200 U/L. If your lab already printed a FIB-4 score, ours may differ by 0.01 because of rounding.
What Your Result Means
These bands come from the US (AASLD) and European (EASL-EASD-EASO) guidance on fatty liver disease⁴ ⁵.
Band | Age under 65 | Age 65 and over | What it suggests |
Low | Below 1.30 | Below 2.00 | Advanced fibrosis is unlikely |
Intermediate | 1.30 to 2.67 | 2.00 to 2.67 | Cannot rule advanced fibrosis in or out |
High | Above 2.67 | Above 2.67 | Advanced fibrosis is more likely |
The 1.30 and 2.67 cutoffs come from a study of 541 adults with fatty liver disease. In that group, 90% of people at or below 1.30 did not have advanced fibrosis, and 80% of people at or above 2.67 did². The middle band is often called the indeterminate zone. The 2.00 cutoff for older adults is explained below³. You may also see 1.45 and 3.25 on some reports and websites. Those are the original cutoffs, set in people with HIV and hepatitis C¹.
How FIB-4 Is Used After a Blood Test
The American Association for the Study of Liver Diseases (AASLD) advises a FIB-4 check for adults with type 2 diabetes, prediabetes, two or more metabolic risk factors, or fat seen on a liver scan, repeated every 1 to 2 years⁴. The European guideline also uses FIB-4 as the first of two steps⁵. A score of 1.30 or more usually leads to a second test. This is often elastography, a quick scan that measures liver stiffness (vibration-controlled transient elastography, often called FibroScan), or the ELF blood test⁴. FIB-4 used alone can give many false alarms, which is why the second step exists⁵.
Older research and some lab reports say NAFLD (nonalcoholic fatty liver disease). In 2023, liver societies renamed it metabolic dysfunction-associated steatotic liver disease (MASLD), which requires at least one of five cardiometabolic risk factors⁶. The FIB-4 cutoffs did not change with the new name⁵.
When FIB-4 Can Be Misleading
Age is part of the formula, so the score rises as you get older even if your liver does not change. In a study of 634 adults with biopsy-confirmed fatty liver disease, about 2 in 3 people aged 65 and over who did not have advanced fibrosis still scored above 1.30. With a cutoff of 2.0, that fell to about 3 in 10 people³. The same study found FIB-4 worked poorly at age 35 and under³. At younger ages, a small age number pulls the score down, so a low result is less reassuring.
Anything that changes AST, ALT or platelets for another reason moves the score too. A 2024 clinical review lists acute inflammation of the liver among the limits of these tests⁸. Hard exercise counts: after one hour of weightlifting, AST and ALT stayed raised for at least 7 days in healthy men who were new to it⁹. For example, a 45-year-old with AST 25, ALT 25 and platelets 250 scores 0.90, but with AST 75 and ALT 40 the same person scores 2.13. Platelet counts can also be low or high for reasons unrelated to the liver, such as bone marrow problems, iron deficiency or a recent infection⁷. Low platelets push FIB-4 up, and high platelets pull it down.
FIB-4 Score Bands by Age
The FIB-4 range for each band. Pick your age group and enter your score to mark it.
- Low: advanced fibrosis is unlikely
- Intermediate: cannot rule it in or out
- High: advanced fibrosis is more likely
Show data table
| Age group | Low: advanced fibrosis is unlikely | Intermediate: cannot rule it in or out | High: advanced fibrosis is more likely |
|---|---|---|---|
| Age under 65 | Below 1.30 | 1.30 to 2.67 | Above 2.67 |
A Note on Accuracy
This calculator does the arithmetic exactly, but FIB-4 is a screening score, not a diagnosis. It is best at ruling out advanced fibrosis, but even then about 1 in 10 people with a low score still have it². It was built and tested in adults with long-term liver conditions, mainly fatty liver disease and hepatitis C. It is less reliable at age 35 and under, after recent liver inflammation or hard exercise, and when platelets are abnormal for other reasons. This uses the numbers on your lab report. Ask the clinician who ordered the test what your result means alongside your other tests.
Frequently Asked Questions
What is a normal FIB-4 score?
A FIB-4 score below 1.30 is in the low-risk band for adults under 65, and below 2.00 for adults 65 and over⁴ ⁵. A low score means advanced liver scarring is unlikely, not that the liver is fully healthy.
What FIB-4 score is considered high?
A score above 2.67 is in the high band at any age. In the study that set this cutoff, 80% of people at or above 2.67 had advanced fibrosis², but doctors use a second test, such as elastography, to confirm it⁴.
What does an indeterminate FIB-4 score mean?
A score from 1.30 to 2.67 (2.00 to 2.67 at age 65 and over) cannot rule advanced fibrosis in or out. Guidelines usually suggest a second test, such as liver elastography or the ELF blood test⁴ ⁵.
How accurate is the FIB-4 score?
It is better at ruling out advanced fibrosis than confirming it: 90% of people with low scores did not have it in the original fatty liver study², so about 1 in 10 people with a low score still had it². Age, recent liver inflammation, hard exercise and platelet problems can all skew the result³ ⁸ ⁹.
Sources
Development of a Simple Noninvasive Index to Predict Significant Fibrosis in HIV/HCV Coinfection, Sterling et al., 2006
Comparison of Noninvasive Markers of Fibrosis in Nonalcoholic Fatty Liver Disease, Shah et al., 2009
Age as a Confounding Factor for the Non-Invasive Diagnosis of Advanced NAFLD Fibrosis, McPherson et al., 2017
AASLD Practice Guidance on Nonalcoholic Fatty Liver Disease, Rinella et al., 2023
EASL-EASD-EASO Clinical Practice Guidelines on MASLD, EASL, EASD and EASO, 2024
A Multi-Society Delphi Consensus Statement on New Fatty Liver Disease Nomenclature, Rinella et al., 2023
Platelet Count, MedlinePlus
A Clinical Review of Noninvasive Tests for Hepatic Fibrosis, Chadha and Sterling, 2024
Muscular Exercise Can Cause Highly Pathological Liver Function Tests in Healthy Men, Pettersson et al., 2008